Alphatec Holdings Inc (ATEC)

Currency in USD
7.075
+0.015(+0.21%)
Real-time Data·
Advertisement
ATEC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.0507.260
52 wk Range
6.81023.290
Key Statistics
Prev. Close
7.06
Open
7.13
Day's Range
7.05-7.26
52 wk Range
6.81-23.29
Volume
2.23M
Average Volume (3m)
3.2M
1-Year Change
-64.9752%
Book Value / Share
-0.015
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATEC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.929
Upside
+82.74%
Members' Sentiments
Bearish
Bullish
ProTips
9 analysts have revised their earnings downwards for the upcoming period

Alphatec Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

12 Buy
2 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 12.929
(+82.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy20.00+181.49%24.00Maintain13/11/2026
UBS
Hold---Downgrade03/11/2026
JPMorgan
Buy15.00+111.12%16.00Maintain30/10/2026
Lake Street
Buy14.00+97.04%15.00Maintain30/10/2026
Stifel
Buy11.00+54.82%13.00Maintain30/10/2026

Alphatec Holdings Inc Earnings Call Summary for Q2/2026

  • Q2 revenue rose 15% YoY to $214M, beating $211.24M forecast; adjusted EBITDA jumped 53% to $36M with margin expanding to 17%.
  • ATEC raised full-year 2026 adjusted EBITDA guidance to $140M from $134M while maintaining revenue guidance at $882M, representing 15% growth.
  • Net new surgeon growth reached 24% and case volume increased 20%, though revenue per case fell 2.7% YoY due to mix pressures and weak biologics.
  • Gross margin improved 260 basis points to 72.5%; free cash flow turned slightly positive at $1M after $33M in inventory and instrument investments.
  • Management expects Q3 free cash flow of $4M-$6M and second-half surgical revenue growth to accelerate to 18% with case volume growth in high teens.
Last Updated: 04/08/2026, 22:58
Read Full Transcript

Earnings

Latest Release
29/10/2026
EPS / Forecast
0.09 / 0.10
Revenue / Forecast
221.17M / 225.44M
EPS Revisions
Last 90 days

Compare ATEC to Peers and Sector

Metrics to compare
ATEC
Peers
Sector
Relationship
P/E Ratio
−12.7x−3.4x−0.2x
PEG Ratio
−0.27−0.200.00
Price/Book
−478.5x2.3x2.6x
Price / LTM Sales
1.3x2.6x2.8x
Upside (Analyst Target)
82.5%120.4%63.4%
Fair Value Upside
Unlock37.7%9.5%Unlock

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
47.56M30.66%349.60M
Other Institutional Investors
87.08M56.13%640.04M
Public Companies & Retail Investors
20.50M13.21%150.64M
Total
155.14M100.00%1.14B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.7.30%11,326,67783,251
Squadron Capital, LLC6.70%10,395,04576,404

People Also Watch

17.76
ARDT
+0.42%
7.760
PBYI
-3.96%
81.21
NVEC
-1.69%

FAQ

What Is the Alphatec Holdings (NASDAQ: ATEC) Share Price Today?

The Alphatec Holdings stock price today is 7.075 USD.

What Stock Exchange Does Alphatec Holdings (ATEC) Trade On?

Alphatec Holdings is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Alphatec Holdings?

The stock symbol (also called a 'ticker') for Alphatec Holdings is "ATEC."

What Is the Current Alphatec Holdings Market Capitalisation?

As of today, Alphatec Holdings (NASDAQ: ATEC) market cap is 1.100B USD.

What Is Alphatec Holdings's (ATEC) Earnings Per Share (TTM)?

The Alphatec Holdings EPS is currently -0.56 (Trailing Twelve Months).

When Is the Next Alphatec Holdings Earnings Date?

Alphatec Holdings's next earnings report will be released on 02/03/2027.

Is ATEC a Buy or Sell From a Technical Analyst Perspective?

Based on today's Alphatec Holdings moving averages and other technical indicators, the daily buy/sell signal for ATEC stock is Strong Sell.

How Many Times Has Alphatec Holdings Stock Split?

Alphatec Holdings has split 1 times. (See the ATEC stock split history page for full effective split date and price information.)

How Many Employees Does Alphatec Holdings Have?

Alphatec Holdings has 913 employees, based on their latest Companies House report.

What is the current trading status of Alphatec Holdings (NASDAQ: ATEC)?

As of 13/11/2026, Alphatec Holdings (ATEC) is trading at a share price of 7.075 USD, with a previous close of 7.060 USD. The stock has fluctuated within a day range of 7.050 USD to 7.260 USD, while its 52-week range spans from 6.810 USD to 23.290 USD.

What Is Alphatec Holdings (ATEC) Price Target According to Analysts?

The average 12-month price target for Alphatec Holdings is 12.929 USD, with a high estimate of 24 USD and a low estimate of 8 USD. 12 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +82.74% Upside potential.

What Is the ATEC Premarket Price?

ATEC's last pre-market stock price is 7.130 USD. The pre-market share volume is 2,340.000, and the stock has decreased by 0.070, or 0.990%.

What Is the ATEC After Hours Price?

ATEC's last after hours stock price is 7.120 USD, the stock has decreased by 0.060, or 0.850%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.